생체활성 재료 시장 : 재료별, 유형별, 용도별, 지역별(2025-2033년)

The global bioactive materials market size reached USD 3.2 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 8.4 Billion by 2033, exhibiting a growth rate (CAGR) of 10.86% during 2025-2033. The escalating demand for regenerative medicine is stimulating the market.

Bioactive materials are constituents that are meant to interact with biological systems, such as cells, tissues, and organs. These materials can be synthetic or natural and are mainly used in a variety of medical applications, including tissue engineering, drug delivery, and regenerative medicine. They can promote specific biological responses, such as cell adhesion, proliferation, and differentiation, by mimicking the extracellular matrix (ECM) of the tissue being targeted. Additionally, they can also be utilized for drug delivery, where the material is designed to release a drug or therapeutic agent over time. This can be useful for targeted drug delivery, where the drug is released directly to the affected tissue, minimizing side effects and improving efficacy. As a result, they are gaining widespread prominence across the globe since bioactive materials have a wide range of applications in the medical field and are an important tool for advancing treatments for various diseases and conditions. Some of the common bioactive materials include hydroxyapatite and polycaprolactone (PCL) that are widely adopted for bone grafts and dental implants and to create scaffolds that promote the growth of new tissue.

Bioactive Materials Market Trends:

The global market is majorly driven by the growing demand for regenerative medicine among patients and healthcare professionals. Coupled with the increasing prevalence of chronic diseases among individuals, leading to a growing need for innovative treatment options, this is providing a boost to the demand for bioactive materials to promote tissue regeneration and repair. Along with this, continual technological advancements in the field of bioactive materials and the development of new and improved materials with enhanced properties, such as biocompatibility, biodegradability, and mechanical strength, are creating a positive market outlook. Furthermore, the growing investments in extensive research and development (R&D) activities to develop new materials and applications are acting as a growth-inducing factor. Apart from this, the escalating funding by private and public agencies to upgrade the overall healthcare infrastructure is impacting the market favorably. Along with this, continuous improvements in the field of biotechnology and life science are significantly supporting the demand for bioactive materials across the globe. Other factors, including rapid urbanization, the growing geriatric population and the development of medical facilities across rural and geographically extended locations, are also positively influencing the market.

Key Market Segmentation:

Material Insights:

• Glass
• Glass-ceramics
• Composite
• Others

Type Insights:

• Powder
• Moldable
• Granules
• Others

Application Insights:

• Dentistry
• Surgery
• Bioengineering
• Others

Regional Insights:

• North America
• United States
• Canada
• Asia Pacific
• China
• Japan
• India
• South Korea
• Australia
• Indonesia
• Others
• Europe
• Germany
• France
• United Kingdom
• Italy
• Spain
• Russia
• Others
• Latin America
• Brazil
• Mexico
• Others
• Middle East and Africa
• The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America was the largest market for bioactive materials. Some of the factors driving the North America bioactive materials market included the growing investment in extensive research and development (R&D) activities, the emerging healthcare infrastructure, the development of medical facilities across rural and geographically extended locations, etc.

Competitive Landscape:

• The report has also provided a comprehensive analysis of the competitive landscape in the global bioactive materials market. Detailed profiles of all major companies have also been provided. Some of the companies covered include Arthrex Inc., BBS-Bioactive Bone Substitutes Oyj, Berkeley Advanced Biomaterials, Biomatlante SAS (Advanced Medical Solutions Group Plc), Ceraver, DePuy Synthes Inc. (Johnson & Johnson), Noraker, PULPDENT Corporation, Regenity Biosciences, etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

Key Questions Answered in This Report:

• How has the global bioactive materials market performed so far, and how will it perform in the coming years?
• What are the drivers, restraints, and opportunities in the global bioactive materials market?
• What is the impact of each driver, restraint, and opportunity on the global bioactive materials market growth?
• What are the key regional markets?
• Which countries represent the most attractive bioactive materials market?
• What is the breakup of the market based on the material?
• Which is the most attractive material in the bioactive materials market?
• What is the breakup of the market based on the type?
• Which is the most attractive type in the bioactive materials market?
• What is the breakup of the market based on the application?
• Which is the most attractive application in the bioactive materials market?
• What is the competitive structure of the global bioactive materials market?
• Who are the key players/companies in the global bioactive materials market?

Table of Contents

1 Preface

2 Scope and Methodology

• 2.1 Objectives of the Study
• 2.2 Stakeholders
• 2.3 Data Sources
  • 2.3.1 Primary Sources
  • 2.3.2 Secondary Sources
• 2.4 Market Estimation
  • 2.4.1 Bottom-Up Approach
  • 2.4.2 Top-Down Approach
• 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

• 4.1 Overview
• 4.2 Key Industry Trends

5 Global Bioactive Materials Market

• 5.1 Market Overview
• 5.2 Market Performance
• 5.3 Impact of COVID-19
• 5.4 Market Forecast

6 Market Breakup by Material

• 6.1 Glass
  • 6.1.1 Market Trends
  • 6.1.2 Market Forecast
• 6.2 Glass-ceramics
  • 6.2.1 Market Trends
  • 6.2.2 Market Forecast
• 6.3 Composite
  • 6.3.1 Market Trends
  • 6.3.2 Market Forecast
• 6.4 Others
  • 6.4.1 Market Trends
  • 6.4.2 Market Forecast

7 Market Breakup by Type

• 7.1 Powder
  • 7.1.1 Market Trends
  • 7.1.2 Market Forecast
• 7.2 Moldable
  • 7.2.1 Market Trends
  • 7.2.2 Market Forecast
• 7.3 Granules
  • 7.3.1 Market Trends
  • 7.3.2 Market Forecast
• 7.4 Others
  • 7.4.1 Market Trends
  • 7.4.2 Market Forecast

8 Market Breakup by Application

• 8.1 Dentistry
  • 8.1.1 Market Trends
  • 8.1.2 Market Forecast
• 8.2 Surgery
  • 8.2.1 Market Trends
  • 8.2.2 Market Forecast
• 8.3 Bioengineering
  • 8.3.1 Market Trends
  • 8.3.2 Market Forecast
• 8.4 Others
  • 8.4.1 Market Trends
  • 8.4.2 Market Forecast

9 Market Breakup by Region

• 9.1 North America
  • 9.1.1 United States
    • 9.1.1.1 Market Trends
    • 9.1.1.2 Market Forecast
  • 9.1.2 Canada
    • 9.1.2.1 Market Trends
    • 9.1.2.2 Market Forecast
• 9.2 Asia-Pacific
  • 9.2.1 China
    • 9.2.1.1 Market Trends
    • 9.2.1.2 Market Forecast
  • 9.2.2 Japan
    • 9.2.2.1 Market Trends
    • 9.2.2.2 Market Forecast
  • 9.2.3 India
    • 9.2.3.1 Market Trends
    • 9.2.3.2 Market Forecast
  • 9.2.4 South Korea
    • 9.2.4.1 Market Trends
    • 9.2.4.2 Market Forecast
  • 9.2.5 Australia
    • 9.2.5.1 Market Trends
    • 9.2.5.2 Market Forecast
  • 9.2.6 Indonesia
    • 9.2.6.1 Market Trends
    • 9.2.6.2 Market Forecast
  • 9.2.7 Others
    • 9.2.7.1 Market Trends
    • 9.2.7.2 Market Forecast
• 9.3 Europe
  • 9.3.1 Germany
    • 9.3.1.1 Market Trends
    • 9.3.1.2 Market Forecast
  • 9.3.2 France
    • 9.3.2.1 Market Trends
    • 9.3.2.2 Market Forecast
  • 9.3.3 United Kingdom
    • 9.3.3.1 Market Trends
    • 9.3.3.2 Market Forecast
  • 9.3.4 Italy
    • 9.3.4.1 Market Trends
    • 9.3.4.2 Market Forecast
  • 9.3.5 Spain
    • 9.3.5.1 Market Trends
    • 9.3.5.2 Market Forecast
  • 9.3.6 Russia
    • 9.3.6.1 Market Trends
    • 9.3.6.2 Market Forecast
  • 9.3.7 Others
    • 9.3.7.1 Market Trends
    • 9.3.7.2 Market Forecast
• 9.4 Latin America
  • 9.4.1 Brazil
    • 9.4.1.1 Market Trends
    • 9.4.1.2 Market Forecast
  • 9.4.2 Mexico
    • 9.4.2.1 Market Trends
    • 9.4.2.2 Market Forecast
  • 9.4.3 Others
    • 9.4.3.1 Market Trends
    • 9.4.3.2 Market Forecast
• 9.5 Middle East and Africa
  • 9.5.1 Market Trends
  • 9.5.2 Market Breakup by Country
  • 9.5.3 Market Forecast

10 Drivers, Restraints, and Opportunities

• 10.1 Overview
• 10.2 Drivers
• 10.3 Restraints
• 10.4 Opportunities

11 Value Chain Analysis

12 Porters Five Forces Analysis

• 12.1 Overview
• 12.2 Bargaining Power of Buyers
• 12.3 Bargaining Power of Suppliers
• 12.4 Degree of Competition
• 12.5 Threat of New Entrants
• 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

• 14.1 Market Structure
• 14.2 Key Players
• 14.3 Profiles of Key Players
  • 14.3.1 Arthrex Inc.
    • 14.3.1.1 Company Overview
    • 14.3.1.2 Product Portfolio
    • 14.3.1.3 SWOT Analysis
  • 14.3.2 BBS-Bioactive Bone Substitutes Oyj
    • 14.3.2.1 Company Overview
    • 14.3.2.2 Product Portfolio
    • 14.3.2.3 Financials
  • 14.3.3 Berkeley Advanced Biomaterials
    • 14.3.3.1 Company Overview
    • 14.3.3.2 Product Portfolio
  • 14.3.4 Biomatlante SAS (Advanced Medical Solutions Group Plc)
    • 14.3.4.1 Company Overview
    • 14.3.4.2 Product Portfolio
  • 14.3.5 Ceraver
    • 14.3.5.1 Company Overview
    • 14.3.5.2 Product Portfolio
  • 14.3.6 DePuy Synthes Inc. (Johnson & Johnson)
    • 14.3.6.1 Company Overview
    • 14.3.6.2 Product Portfolio
  • 14.3.7 Noraker
    • 14.3.7.1 Company Overview
    • 14.3.7.2 Product Portfolio
  • 14.3.8 PULPDENT Corporation
    • 14.3.8.1 Company Overview
    • 14.3.8.2 Product Portfolio
  • 14.3.9 Regenity Biosciences
    • 14.3.9.1 Company Overview
    • 14.3.9.2 Product Portfolio

Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.